The prevalence of diabetes mellitus is increasing at an alarming rate worldwide. With no cure available, effective disease management is the best way to control disease progression. Studies have shown that diabetes technology helps to improve health outcomes and the quality of life of the patients. Diabetes technology can be defined as any solution encompassing hardware, devices, and software used in the disease management of patients. This review serves as an introduction to diabetes mellitus by discussing the different categories of well-established diabetes technology, related ongoing research, and its challenges. This review is divided into 3 main categories, insulin administration, glucose monitoring, and hybrid devices that combine the 2 categories into one. Digital health application is also discussed as it is becoming a notable tool in the disease management of diabetes. Widespread use of these devices in disease management has been increasing in recent years. However, there are still barriers that prevent the utilization of the full potential of these devices.
Background: Cordyceps militaris (C. militaris) is a medicinal mushroom recognized for its diverse pharmacological activities, largely attributed to its principal bioactive nucleosides, cordycepin and adenosine. Although accumulating evidence supports their neuroprotective potential, the molecular mechanisms underlying their effects against Alzheimer’s disease (AD) remain incompletely understood. This study investigated the neuroprotective effects of cordycepin and adenosine against amyloid-β (Aβ42)-induced neurotoxicity and explored their potential molecular mechanisms using integrated experimental and computational approaches. Methods: SH-SY5Y neuroblastoma cells were pretreated with cordycepin (COR), adenosine (ADE), or donepezil (DNPZ) prior to Aβ42 exposure, and cell viability was assessed using the MTT assay. Drug-likeness and absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties were evaluated in silico, followed by network pharmacology to identify potential therapeutic targets and enriched biological pathways. Molecular docking and molecular dynamics simulations were performed to elucidate the interactions of the compounds with selected Alzheimer’s disease-related proteins. Results: COR and ADE significantly attenuated Aβ42-induced cytotoxicity and improved SH-SY5Y cell viability. Network pharmacology identified 84 shared molecular targets, including 9 AD-associated genes. Protein–protein interaction analysis revealed hub genes involved in signal transduction, epigenetic regulation, and purine metabolism, while Gene Ontology and KEGG enrichment analyses highlighted pathways associated with neuroactive ligand–receptor interaction, calcium signaling, and inflammatory regulation. ADMET analysis predicted favorable pharmacokinetic properties for both compounds, although cordycepin was predicted to be AMES-positive. Molecular docking and molecular dynamics simulations demonstrated stable interactions of COR and ADE with liver X receptors (LXRα and LXRβ), whereas donepezil exhibited stronger binding affinity toward β-secretase (BACE1). Conclusions: COR and ADE exert neuroprotective effects through coordinated modulation of multiple AD-related signaling pathways rather than a single molecular target. These findings provide mechanistic insights into the neuroprotective activities of C. militaris-derived nucleosides and support further investigation of their potential as multi-target therapeutic candidates for AD and other neurodegenerative disorders.
15 January 2025 in Progress In Microbes & Molecular Biology
Autophagy, a crucial cellular process for maintaining homeostasis, plays a significant role in the degradation and recycling of cellular components. Dysregulation of autophagy has been implicated in numerous diseases, including neurodegenerative disorders, cancer, and metabolic conditions. Given the increasing interest in natural, plant-derived compounds for their therapeutic potential, understanding how these compounds influence autophagy is vital. This review aims to provide a comprehensive analysis of the molecular mechanisms through which natural compounds regulate different types of autophagy by targeting specific markers and regulatory signaling pathways such as AMPK, mTOR, and AKT. It also aims to highlight the current gaps in the literature and suggest future research directions to understand these relationships. Research is conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Studies were extracted from different databases (Scopus, PubMed and Google Scholar) up to 28 February 2024. Inclusion criteria included original studies published in English that examined pure botanical compounds from plant species with direct association to autophagy pathways. A total of 3056 studies, comprised of 68 cell-based studies, 55 animal-based studies, and 39 studies that employed both models were analysed and categorized according to their botanical families and species with a focus on their autophagy activities. This review identified a total of 103 studies investigating the effects of pure compounds on macroautophagy, 2 studies examining microautophagy, and no studies focusing solely on chaperone-mediated autophagy (CMA). However, 4 studies explored the combined effects of macroautophagy and CMA. Additionally, 9 studies focused exclusively on autophagy-related signaling pathways alone, while 40 investigated both macroautophagy and signaling pathways. It highlights the significant role that isolated bioactive compounds from botanical species play in the regulation of autophagy across a range of diseases and future studies can build upon the findings to pave the way for the development of effective plant-based therapies targeting autophagy pathways for disease treatment.